T-cell recognition of non-mutated tumor antigens in healthy individuals: connecting endogenous immunity and tumor dormancy Constantin N. Baxevanis Commentary 06 April 2019 Pages: 705 - 707
Natural T cell autoreactivity to melanoma antigens: clonally expanded melanoma-antigen specific CD8 + memory T cells can be detected in healthy humans Anna PrzybylaTing ZhangPaul V. Lehmann Original Article Open access 19 February 2019 Pages: 709 - 720
Imbalances in cellular immunological parameters in blood predetermine tumor onset in a natural mouse model of breast cancer Dmitry A. AronovViacheslav V. ZhukovEkaterina V. Moiseeva Original Article 11 February 2019 Pages: 721 - 729
Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma Ying XiongLi LiuJiejie Xu Original Article 13 February 2019 Pages: 731 - 741
Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma Izak FaienaStephanie H. AstrowAlexandra Drakaki Original Article 21 February 2019 Pages: 743 - 751
Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model Jamile R. SilvaNatiely S. SalesMariana O. Diniz Original Article 26 February 2019 Pages: 753 - 763
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis Bastian SchillingAlexander MartensBenjamin Weide Original Article 26 February 2019 Pages: 765 - 772
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2 Linh T. NguyenSamuel D. SaibilMarcus O. Butler Clinical Trial Report Open access 11 February 2019 Pages: 773 - 785
Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus Inge M. WerterCharlotte M. Huijtsfor the Dutch WIN-O Consortium Clinical Trial Report Open access 11 February 2019 Pages: 787 - 798
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer Martin SebastianAndreas SchröderSven D. Koch Clinical Trial Report 15 February 2019 Pages: 799 - 812
Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET–CT Antonia Dimitrakopoulou-Strauss Focussed Research Review 19 August 2018 Pages: 813 - 822
Opposing roles of eosinophils in cancer Sonja C. S. SimonJochen UtikalViktor Umansky Focussed Research Review 09 October 2018 Pages: 823 - 833
Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism Jingjing ZhuPierre-Florent PetitBenoit J. Van den Eynde Focussed Research Review 07 November 2018 Pages: 835 - 847
An alphavirus-based therapeutic cancer vaccine: from design to clinical trial Amrita SinghGeorgia KoutsoumpliToos Daemen Focussed Research Review Open access 21 November 2018 Pages: 849 - 859
Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy Beatriz Sanchez-CorreaNelson Lopez-SejasRaquel Tarazona Focussed Research Review 05 April 2019 Pages: 861 - 870